Summary In order to determine whether low plasma levels of retinol and its carrier (retinol binding protein) are related to increased risk of cancer recurrence, these were measured in 103 patients who had had colorectal cancer surgically removed. According to the modification of the Dukes' classification, 66 had B2 tumours (with no nodal involvement' and 37 had C tumours (with lymph-node metastases). These patients were part of the Cross Cancer Institute Adjuvant GI Cohorts who were on the control arms receiving no further treatment. At the time of blood sample collection, they were believed to be free of neoplastic disease. The post-operative patients were found to be associated with subnormal circulatory levels of retinol (43.3 pg dl-1 vs 65.3 pg dl-1) and its carrier protein (4.6mg dl-1 vs 5.7 mgdl-1), when compared with apparently healthy subjects. The latter being more markedly depressed in patients with "C" type tumour (3.8 mgdl-1) than that in those with "B2" type tumour (5.0mg dl-1). These findings appeared to be persistent during the follow-up study when a second blood sample was collected, one to four months later from 40 patients. Furthermore, the initial plasma retinol level in conjunction with RBP was found to be even lower in 12 patients (35.1 pg dl-1, 3.7 mg dl -1) who subsequently had cancer recurrence than in those who remained free of apparent cancer (44.5 g dl -1, 4.6 mg dl -1). The lowest initial values of retinol (19.3 pg; 18.8 pg dl-1) and RBP (2.4; 1.6 mg dl -1) recorded in the study were seen in the only two patients who died of the disease at the time of follow-up.
The evidence to support a link between retinol deficiency and cancer in man comes primarily from three sources. These are epidemiological studies of dietary intake and cancer incidence (Bjelke, 1975; Hirayama, 1979; Mettlin & Graham, 1979; Graham et al., 1981) ; biochemical studies involving comparison of plasma retinol levels in cancer cases and controls (Basu et al., 1976 Ibrahim et al., 1977; Atukorala et al., 1979;  and biochemical studies of retinol status in those who are destined to develop cancer (Wald et al., 1980; Kark et al., 1981) . These studies have consistently implied that low plasma or dietary intake of retinol may be associated with increased risk of developing cancer. However, there is little or no information in the literature showing a relationship between retinol status and subsequent cancer recurrence in patients who had undergone curative surgery. The present study was undertaken to investigate whether lower plasma retinol is associated with increased risk of cancer recurrence in post-operative, apparently disease-free colorectal cancer patients.
The mobilization and transportation of retinol from liver storage requires hydrolysis of the retinyl esters followed by conjugation of the free retinol with a specific transport protein, retinol-binding protein (RBP) produced by the liver. The holoCorrespondence: T.K. Basu. Received 12 July 1984; and in revised form 9 October 1984. protein is then released to the circulation where it binds to prealbumin as a 1:1 molar complex. The resulting complex transports retinol to target organs (Goodman, 1974; Peterson et al., 1974) . In order to determine the metabolically available retinol, the plasma level of RBP was measured in conjunction with retinol.
Patients and methods

Patients
A 10-year follow-up of 487 cases of colorectal cancer at the W.W. Cross Cancer Institute (WWCCI) in Edmonton, Alberta showed an overall 5-year survival of 35% (McCarten & Preston, 1973 ). An ongoing randomized prospective surgical adjuvant GI trial involving Dukes' B2 (with full thickness of the bowel wall but no nodal involvement) and C (with regional lymph-node metastases) colorectal carcinoma was initiated in 1976 at the WWCCI. Patients entering into this trial were randomly assigned into one of the three groups including control receiving no adjuvant treatment, immunotherapy, and chemoimmunotherapy. All patients considered for the study were entered as randomized only if informed consent was given. Patients were ineligible if they had had preoperative radiotherapy, chemotherapy or immunotherapy within the previous year. The main assess-ment of the trial is survival which will be calculated for each patient allocated from the data of definite resection.
The present study was an integral part of the WWCCI trial. A total of 103 patients who were on the control arm of the surgical adjuvant trial were assigned to this investigation. All Methods Non-fasting blood samples were drawn from all subjects in EDTA tubes. The samples were wrapped with foil during transportation from the WWCCI and the Red Cross Blood Transfusion Clinics to the laboratory, thus minimizing the loss of vitamin A which is sentitive to light. The separated plasma samples were stored at -35°C until analyzed. Retinol was determined in the plasma by a modification (Steveninck & DeGoeij, 1973) of the fluorometric method of Hansen & Warwick (1968) .
In this method, fluorescence was measured at an emission wavelength of 550nm where interference from carotenoids was virtually zero. To determine the metabolically available retinol, plasma concentrations of RBP were determined by the single radial immunodiffusion technique (Mancini et al., 1965) using LC-partigen immunodiffusion plates (Behring Diagnostics).
All biochemical analyses were performed blind, i.e. the classification of the patients was not known during the study. One-way analysis of variance was used to determine the significant differences between the means of the different groups for each of the variables. The student t-test was used to determine if there was a significant difference between means of any two groups. A pairwise t-test was used to identify any significant change between the first and second samples for patients who had serial samples.
Results
The plasma concentrations of retinol and RBP in the control subjects did not appear to be subject to age and sex variations (23-65 years). Furthermore, the mean values of the indices obtained in these subjects were found to be similar to those reported by others involving control subjects with age groups matched with the age of the patients (23-80 years) included in the present study (Willett et al., 1984; Stich et al., 1984) . The results of our control subjects as a group, irrespective of age and sex, were therefore compared with that of the postoperative colorectal cancer patients. Table II shows the mean differences in plasma retinol and RBP between control subjects and the post-operative colorectal cancer patients who appeared to be disease-free. Both groups (B2 and C) of disease-free cancer patients were found to be associated with not only subnormal plasma retinol levels (P<0.001), but also lower RBP levels (P<0.01) than the "control" subjects. Statistical difference of the RBP levels between "controls" and the patients with "C" type colorectal cancer appeared to be more marked (P<0.001) than the difference between "controls" and the patients with "B2" type cancer.
No differences between the cancer sites for retinol and RBP were observed as determined by oneway analysis of variance. Patients were grouped together by period intervals from the date of surgery to the date of blood sample collection. The shortest interval (<2 months) was associated with the lowest average mean of plasma retinol and RBP levels, while during the period of 6-12 months following surgery, the average mean values of the indices were found to be at their maximum levels. Analysis of variance, however, revealed no overall significant difference in these parameters between the various intervals of time. Of the 103 patients, 40 had serial samples taken at two different periods of time. The time interval between the first and second samples ranged from less than one month to 4 months with an average time difference of 2-6 months. No significant differences in plasma concentrations of retinol and RBP were observed between the two periods of time. In follow-up studies to date, of the 103 apparently disease-free colorectal cancer patients, a total of 12 subjects (from both B2 and C groups) subsequently had a recurrence of the disease who showed lower plasma levels of retinol as well as RBP, then those who remained disease-free (Table III) . However, when Table II where the recurrent cases were included.
It was interesting to note that plasma concentrations of retinol and RBP were very low in two recurrent patients who died of the disease during this study (Table IV) .
Discussion
Plasma from healthy blood donors was used merely to standardize the methodologies for both retinol and RBP. Since these subjects had no recent surgery, limited conclusions can be drawn from comparisons of the post-operative colorectal cancer patients' values to these normals. However, it is interesting to note that although the patients were seemingly free of colorectal cancer, they had subnormal levels of plasma retinol when compared with the apparently healthy subjects (43.3pgdl-1 vs 65.3pgdl-1). This finding is consistent irrespective of either the stage of the disease or the site of the tumour at the time of diagnosis.
Subnormal levels of plasma retinol have been reported in cancers of the bronchus (Basu et al., 1976) ; lung (Atukorala et al., 1979) ; oropharynx (Ibrahim et al., 1977) and GI tract (Abels et al., 1941) . In these studies, blood samples were taken from patients who still had a tumour. It is, therefore, possible that their appetite was depressed due to the presence of the tumour, or the tumour itself may have lowered retinol levels due to its increased requirement. Moreover, the treatment of the disease by either chemotherapy or radiotherapy may have resulted in nutritional problems (Dewys & Walters, 1975) .
It is noteworthy to point out that the patients in the present study had already undergone resection of their carcinoma, and were believed to be free of neoplastic disease following surgery when the blood samples were collected. In addition, these patients were not undergoing any kind of therapy, and yet they were found to have subnormal circulating levels of retinol. This was true, not only when the blood samples were collected soon after surgery, but also in the subsequent samples collected 1-4 months later.
The low plasma retinol in the postoperative colorectal cancer patients appears to be associated with subnormal plasma levels of RBP. Since retinol is transported to the circulation bound to RBP, the low plasma retinol in the colorectal cancer patients may be the result of a lower concentration of the carrier protein.
With the exception of one study (Willett et al., 1984) , most studies have indicated that subnormal plasma retinol levels exist long before the appearance of a tumour. Thus, low circulating levels of the vitamin were observed in subjects who subsequently developed cancer of epithelial cell origin (Wald et al., 1980; Kark et al., 1981) . However, in a case-control study, the plasma concentrations of RBP were found to be normal in samples taken 2-7 years before the development of clinically manifested lung tumours (Haines et al., 1982) . While there have been a number of studies showing low concentrations of both plasma retinol and RBP in patients with an established tumour (Atukorala et al., 1979; Basu et al., 1982) .
It is possible that the circulating level of RBP could be used as a possible tumour marker. Such a hypothesis is further substantiated by the observations made in the present study where colorectal cancer patients with (Dukes' C) or without (Dukes' B2) regional lymph-node metastases were found to be associated with subnormal plasma retinol levels, while RBP levels appeared to be more markedly affected in patients with regional lymph-node metastases than those without. Furthermore, in followup studies to Nonetheless, the results of this study appear to suggest that plasma retinol levels in the postoperative disease-free colorectal cancer patient are lower than those in normals, lower plasma RBP levels may be correlated with more advanced stages of resected disease, and there may be a correlation between poor metabolic vitamin A status and subsequent relapse. These observations may have prognostic and predictive significance in colorectal cancer. Further work is certainly warranted to establish whether retinol supplementations raise the circulatory levels of the vitamin or would this not occur due to metabolic unavailability of retinol as a result of reduced RBP levels.
